CA
DCGN

CapWealth Advisors’s DECODE GENETICS INC DCGN Stock Holding History

CapWealth Advisors’s Portfolio DCGN Stock Details DCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-200
Closed – – 330
2016
Q2 		$0 Hold
200
– – ﹤0.01% 332
2016
Q1 		$0 Hold
200
– – ﹤0.01% 333
2015
Q4 		$0 Hold
200
– – ﹤0.01% 285
2015
Q3 		$0 Hold
200
– – ﹤0.01% 309
2015
Q2 		$0 Hold
200
– – ﹤0.01% 332
2015
Q1 		$0 Buy
+200
New – ﹤0.01% 320
2014
Q4 		– Sell
-200
Closed – – 346
2014
Q3 		$0 Hold
200
– – ﹤0.01% 409
2014
Q2 		$0 Buy
+200
New – ﹤0.01% 411

CapWealth Advisors's DCGN Position: Q3 2016 in Review

CapWealth Advisors sold out of DECODE GENETICS INC (DCGN) in Q3 2016, closing a stake of 200 shares.

CapWealth Advisors first reported a position in DCGN in Q2 2014 and held it in 8 quarters. The position peaked at $0 in Q2 2016. 1 fund tracked by Wall St. Rank holds DCGN as of Q3 2016.

  • CapWealth Advisors reported no remaining DECODE GENETICS INC position as of Q3 2016 after selling out during the quarter.
  • CapWealth Advisors sold 200 DECODE GENETICS INC shares in Q3 2016.
  • CapWealth Advisors first reported a position in DECODE GENETICS INC in Q2 2014 and held it in 8 quarters.
  • CapWealth Advisors's DECODE GENETICS INC position peaked at $0 in Q2 2016.
  • 1 fund tracked by Wall St. Rank held DECODE GENETICS INC as of Q3 2016.

Based on CapWealth Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.